AKANVSOBIO• 7 Days (Normalized)
AKAN vs OBIO (Akanda Corp. vs Orchestra BioMed Holdings Inc.)
Showing Closing Date Range from Sep, 09 to Sep, 16, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
AKAN Performance $2.72
-16.31%
Akanda Corp.
Normalized Baseline0.00%
OBIO Performance $6.04
+%
Orchestra BioMed Holdings Inc.
Normalized Baseline0.00%
Alpha Spread Margin OBIO LEADS
-16.31%
OBIO outperforming by 16.31%
AKANOBIO
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
AKAN OBIO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(6 dates)
| Date | AKAN Price | AKAN Gain (%) | OBIO Price | OBIO Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 16, 2026 | $2.72 | -16.31% | $- | - | |
| Sep 15, 2026 | $2.66 | -18.15% | $6.04 | +10.83% | -28.98% |
| Sep 14, 2026 | $2.79 | -14.15% | $5.90 | +8.26% | -22.41% |
| Sep 11, 2026 | $3.07 | -5.54% | $6.12 | +12.29% | -17.83% |
| Sep 10, 2026 | $3.00 | -7.69% | $5.81 | +6.61% | -14.30% |
| Sep 09, 2026 | $3.25 | +0.00% | $5.45 | +0.00% | +0.00% |